help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ott, T. R.
Right arrow Articles by Millar, R. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ott, T. R.
Right arrow Articles by Millar, R. P.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Molecular Endocrinology 16 (5): 1079-1088
Copyright © 2002 by The Endocrine Society

Two Mutations in Extracellular Loop 2 of the Human GnRH Receptor Convert an Antagonist to an Agonist

Thomas R. Ott, Brigitte E. Troskie, Roger W. Roeske, Nicola Illing, Colleen A. Flanagan and Robert P. Millar

Medical Research Council Human Reproductive Sciences Unit (T.R.O., R.P.M.), Edinburgh EH3 9ET, United Kingdom; Departments of Clinical Laboratory Sciences (T.R.O., B.E.T., C.A.F., R.P.M.) and Medicine (C.A.F.), University of Cape Town Medical School, Observatory 7925, South Africa; Indiana University School of Medicine (R.W.R.), Indianapolis, Indiana 46202; and Department of Molecular and Cellular Biology (N.I.), University of Cape Town, Rondebosch 7700, South Africa

Address all correspondence and requests for reprints to: Robert P. Millar, Medical Research Council Human Reproductive Sciences Unit, 37 Chalmers Street, Edinburgh EH3 9ET, United Kingdom. E-mail: r.millar{at}hrsu.mrc.ac.uk.

GnRH regulates the reproductive system through cognate G protein-coupled receptors in vertebrates. Certain GnRH analogs that are antagonists at mammalian receptors behave as agonists at Xenopus laevis and chicken receptors. This phenomenon provides the opportunity to elucidate interactions and the mechanism underlying receptor activation. A D-Lys(iPr) in position 6 of the mammalian GnRH receptor antagonist is required for this agonist activity (inositol phosphate production) in the chicken and X. laevis GnRH receptors. Chimeric receptors, in which extracellular loop domains of the human GnRH receptor were substituted with the equivalent domains of the X. laevis GnRH receptor, identified extracellular loop 2 as the determinant for agonist activity of one of the mammalian antagonists: antagonist 135-18. Site-directed mutagenesis of nine nonconserved residues in the C-terminal domain of extracellular loop 2 of the human GnRH receptor showed that a minimum of two mutations (Val5.24(197)Ala and Trp5.32(205)His) is needed in this region for agonist activity of antagonist 135-18. Agonist activity of antagonist 135-18 was markedly decreased by low pH (<7.0) compared with GnRH agonists. These findings indicate that D-Lys(iPr)6 forms a charge-supported hydrogen bond with His5.32(205) to stabilize the receptor in the active conformation. This discovery highlights the importance of EL-2 in ligand binding and receptor activation in G protein-coupled receptors.




This article has been cited by other articles:


Home page
 Mol. Pharmacol.Home page
K. H. Ahn, A. C. Bertalovitz, D. F. Mierke, and D. A. Kendall
Dual Role of the Second Extracellular Loop of the Cannabinoid Receptor 1: Ligand Binding and Receptor Localization
Mol. Pharmacol., October 1, 2009; 76(4): 833 - 842.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
S. Sundaram, C. Durairaj, R. Kadam, and U. B. Kompella
Luteinizing hormone-releasing hormone receptor-targeted deslorelin-docetaxel conjugate enhances efficacy of docetaxel in prostate cancer therapy
Mol. Cancer Ther., June 1, 2009; 8(6): 1655 - 1665.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. D. G. Pfleger, A. J. Pawson, and R. P. Millar
Changes to Gonadotropin-Releasing Hormone (GnRH) Receptor Extracellular Loops Differentially Affect GnRH Analog Binding and Activation: Evidence for Distinct Ligand-Stabilized Receptor Conformations
Endocrinology, June 1, 2008; 149(6): 3118 - 3129.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Hu, J. Jiang, S. Costanzi, C. Thomas, W. Yang, J. H. M. Feyen, K. A. Jacobson, and A. M. Spiegel
A Missense Mutation in the Seven-transmembrane Domain of the Human Ca2+ Receptor Converts a Negative Allosteric Modulator into a Positive Allosteric Modulator
J. Biol. Chem., July 28, 2006; 281(30): 21558 - 21565.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
D. K. Barnett, T. M. Bunnell, R. P. Millar, and D. H. Abbott
Gonadotropin-Releasing Hormone II Stimulates Female Sexual Behavior in Marmoset Monkeys
Endocrinology, January 1, 2006; 147(1): 615 - 623.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. E. Ratcliffe, H. M. Fraser, R. Sellar, J. Rivier, and R. P. Millar
Bifunctional Gonadotropin-Releasing Hormone Antagonist-Progesterone Analogs with Increased Efficacy and Duration of Action
Endocrinology, January 1, 2006; 147(1): 571 - 579.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Maudsley, L. Davidson, A. J. Pawson, R. Chan, R. L. de Maturana, and R. P. Millar
Gonadotropin-Releasing Hormone (GnRH) Antagonists Promote Proapoptotic Signaling in Peripheral Reproductive Tumor Cells by Activating a G{alpha}i-Coupling State of the Type I GnRH Receptor
Cancer Res., October 15, 2004; 64(20): 7533 - 7544.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. J. Reinhart, Q. Xie, X.-J. Liu, Y.-F. Zhu, J. Fan, C. Chen, and R. S. Struthers
Species Selectivity of Nonpeptide Antagonists of the Gonadotropinreleasing Hormone Receptor Is Determined by Residues in Extracellular Loops II and III and the Amino Terminus
J. Biol. Chem., August 13, 2004; 279(33): 34115 - 34122.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
P. M. Gault, K. Morgan, A. J. Pawson, R. P. Millar, and G. A. Lincoln
Sheep Exhibit Novel Variations in the Organization of the Mammalian Type II Gonadotropin-Releasing Hormone Receptor Gene
Endocrinology, May 1, 2004; 145(5): 2362 - 2374.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
R. P. Millar, Z.-L. Lu, A. J. Pawson, C. A. Flanagan, K. Morgan, and S. R. Maudsley
Gonadotropin-Releasing Hormone Receptors
Endocr. Rev., April 1, 2004; 25(2): 235 - 275.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Davidson, A. J. Pawson, R. P. Millar, and S. Maudsley
Cytoskeletal Reorganization Dependence of Signaling by the Gonadotropin-releasing Hormone Receptor
J. Biol. Chem., January 16, 2004; 279(3): 1980 - 1993.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. Xu, X. Luo, and N. Chegini
Differential Expression, Regulation, and Induction of Smads, Transforming Growth Factor-{beta} Signal Transduction Pathway in Leiomyoma, and Myometrial Smooth Muscle Cells and Alteration by Gonadotropin-Releasing Hormone Analog
J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1350 - 1361.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
K. D. G. Pfleger, J. Bogerd, and R. P. Millar
Conformational Constraint of Mammalian, Chicken, and Salmon GnRHs, But Not GnRH II, Enhances Binding at Mammalian and Nonmammalian Receptors: Evidence for Preconfiguration of GnRH II
Mol. Endocrinol., September 1, 2002; 16(9): 2155 - 2162.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society